We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01170897
Recruitment Status : Completed
First Posted : July 27, 2010
Last Update Posted : January 29, 2014
Information provided by (Responsible Party):
Halozyme Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2013
  Study Completion Date : January 2014